Efavirenz significantly affects pharmacokinetic exposure of artemether-lumefantrine in HIV-infected Ugandan adults

被引：0

作者：

Byakika-Kibwika, P. ^{[1
]}

机构：

[1] Makerere Univ, Infect Dis Inst, Kampala, Uganda

来源：

TROPICAL MEDICINE & INTERNATIONAL HEALTH | 2012年 / 17卷

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：40 / 41

页数：2

共 50 条

[21] TREATMENT OUTCOMES FOR UNCOMPLICATED MALARIA IN HIV INFECTED ADULTS PATIENTS ON ANTI-RETROVIRAL THERAPY TREATED WITH ARTEMETHER-LUMEFANTRINE [J].

Maganda, B. ;

Minzi, O. ;

Sasi, P. .

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 :90-90

[22] Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa [J].

Sinxadi, Phumla Z. ;

Leger, Paul D. ;

McIlleron, Helen M. ;

Smith, Peter J. ;

Dave, Joel A. ;

Levitt, Naomi S. ;

Maartens, Gary ;

Haas, David W. .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (01) :146-156

[23] Association between exposure to Efavirenz and substrates of dysrhythmia in HIV-infected young adults [J].

Hosseini, Zahra ;

Mollazadeh, Reza ;

Dehghan-Manshadi, Seyed-Ali ;

Mohebi, Mehrnaz ;

Eslami, Masoud ;

Sadre-Bafghi, Seyed-Ali ;

Akbari, Ali ;

Ghodsi, Saeed .

CLINICAL CARDIOLOGY, 2021, 44 (10) :1448-1456

[24] The Impact of Extended Treatment With Artemether-lumefantrine on Antimalarial Exposure and Reinfection Risks in Ugandan Children With Uncomplicated Malaria: A Randomized Controlled Trial [J].

Whalen, Meghan E. ;

Kajubi, Richard ;

Goodwin, Justin ;

Orukan, Francis ;

Colt, McKenzie ;

Huang, Liusheng ;

Richards, Kacey ;

Wang, Kaicheng ;

Li, Fangyong ;

Mwebaza, Norah ;

Aweeka, Francesca T. ;

Parikh, Sunil .

CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) :443-452

[25] Pharmacokinetic interaction of amprenavir in combination with efavirenz or delavirdine in HIV-infected children [J].

Wintergerst, U ;

Engelhorn, C ;

Kurowski, M ;

Hoffmann, F ;

Notheis, G ;

Belohradsky, BH .

AIDS, 2000, 14 (12) :1866-1868

[26] Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected patients with tuberculosis [J].

Lopez-Cortes L.F. ;

Ruiz-Valderas R. ;

Pompyo V. ;

Aristides A.-G. ;

Gomez-Mateos J. ;

Leon-Jimenez E. ;

Sarasa-Nacenta M. ;

Lopez-Pua Y. ;

Pachon J. .

Clinical Pharmacokinetics, 2002, 41 (9) :681-690

[27] Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected patients with tuberculosis [J].

López-Cortés, LF ;

Ruiz-Valderas, R ;

Viciana, P ;

Alarcón-González, A ;

Gómez-Mateos, J ;

León-Jimenez, E ;

Sarasa-Nacenta, M ;

López-Pua, Y ;

Pachón, J .

CLINICAL PHARMACOKINETICS, 2002, 41 (09) :681-690

[28] Effect of albumin and CYP2B6 polymorphisms on exposure of efavirenz: A population pharmacokinetic analysis in Chinese HIV-infected adults [J].

Meng, Xian-min ;

Li, Zi-ran ;

Zheng, Xin-yin ;

Liu, Yi-xi ;

Niu, Wan-jie ;

Qiu, Xiao-yan ;

Lu, Hong-zhou .

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 167

[29] Interaction between Artemether-Lumefantrine and Nevirapine-Based Antiretroviral Therapy in HIV-1-Infected Patients [J].

Kredo, T. ;

Mauff, K. ;

Van der Walt, J. S. ;

Wiesner, L. ;

Maartens, G. ;

Cohen, K. ;

Smith, P. ;

Barnes, K. I. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (12) :5616-5623

[30] The effect of malaria on mortality in a cohort of HIV-infected Ugandan adults [J].

Quigley, MA ;

Hewitt, K ;

Mayanja, B ;

Morgan, D ;

Eotu, H ;

Ojwiya, A ;

Whitworth, JAG .

TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2005, 10 (09) :894-900

← 1 2 3 4 5 →